The novel aldosterone synthase inhibitor yielded particularly robust blood pressure reduction in trial participants with obesity.
Read MoreWhen Designing a Cancer Facility, Patient Outcomes Come First
A look at Cleveland Clinic’s future 377,000-square-foot cancer building.
New Program Name Reflects Blood and Marrow Transplant Progress
Research advances, better treatment protocols improve outcomes
MP-MRI-US Fusion Targeted Biopsy: A Promising New Diagnostic Tool for Prostate Cancer
Specialized software now combines multiparametric MRI and transrectal ultrasound images to improve targeted biopsy of suspicious lesions. The technology has the potential to significantly improve localization and characterization of prostate cancer when added to a 12-core biopsy.